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ClC-K channels form a subgroup of anion channels within the ClC family of anion transport 
proteins. They are expressed predominantly in the kidney and in the inner ear, and are necessary 
for NaCl resorption in the loop of Henle and for K+ secretion by the stria vascularis. Subcellular 
distribution as well as the function of these channels are tightly regulated by an accessory 
subunit, barttin. Barttin improves the stability of ClC-K channel protein, stimulates the exit from 
the endoplasmic reticulum and insertion into the plasma membrane and changes its function 
by modifying voltage-dependent gating processes. The importance of ClC-K/barttin channels 
is highlighted by several genetic diseases. Dysfunctions of ClC-K channels result in Bartter 
syndrome, an inherited human condition characterized by impaired urinary concentration. 
Mutations in the gene encoding barttin, BSND, affect the urinary concentration as well as the 
sensory function of the inner ear. Surprisingly, there is one BSND mutation that causes deafness 
without affecting renal function, indicating that kidney function tolerates a reduction of anion 
channel activity that is not sufficient to support normal signal transduction in inner hair cells. This 
review summarizes recent work on molecular mechanisms, physiology, and pathophysiology 
of ClC-K/barttin channels.
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ClC-3, ClC-4, ClC-5, ClC-6, and ClC-7 reside predominantly in 
intracellular compartments (Günther et al., 1998; Friedrich et al., 
1999; Stobrawa et al., 2001; Wang et al., 2006; Graves et al., 2008; 
Neagoe et al., 2010). They function as coupled antiporters of Cl− and 
H+ (Picollo and Pusch, 2005; Scheel et al., 2005; Graves et al., 2008; 
Neagoe et al., 2010), presumably with a two Cl−: one H+  stoichiometry 
(Graves et al., 2008; Zifarelli and Pusch, 2009). The physiological role 
of these transporters is illustrated by rare human syndromes that 
are associated with impaired endosomal function and are caused 
by mutations in the genes encoding ClC-5 (CLCN5) (Lloyd et al., 
1996) or ClC-7 (CLCN7) (Kornak et al., 2001). Intracellular ClCs 
were initially suggested to provide a shunt conductance in order to 
support electrogenic proton transport by V-type ATPases (Günther 
et al., 1998). However, work with engineered mice carrying ClC 
mutants that solely support passive anion transport demonstrated 
that this transport function is not sufficient to prevent pathological 
conditions found in ClC-5 and ClC-7 knock-out mice (Novarino 
et al., 2010; Weinert et al., 2010). Coupled anion–proton transport 
thus rather serves establishment of high intravesicular [Cl−].
ClC channels exhibit several functional properties that differ 
from other channel families. The existence of anion channels and 
transporters in the same family illustrates the functional similarity of 
ion channels and transporters. ClC proteins display a unique func-
tional stoichiometry. They are dimeric proteins with two  subunits 
and two independent active centers (Dutzler et al., 2002). For ClC 
channels, this peculiar structure gives rise to the appearance of single 
channel openings with two conductance states (Miller, 1982; Saviane 
et al., 1999; Fischer et al., 2010). Moreover, in double-barreled ClC 
channels two structurally distinct types of gating transitions occur, 
fast protopore gating and slow common gating (Miller, 1982; Saviane 
et al., 1999; Zuniga et al., 2004; de Santiago et al., 2005; Fischer et al., 
2010). For fast gating of ClC-0, ClC-1, and ClC-2, a highly conserved 
ClC Channels and transporters
The ClC family of anion channels and transporters is the largest 
known family of anion transport proteins (Jentsch, 2008). It was 
identified by Jentsch et al. (1990), when they cloned a chloride 
channel, ClC-0, from the electric organ of Torpedo. In the follow-
ing years a large number of homologs was identified in a variety 
of organisms and shown to serve multiple physiological functions 
(Jentsch, 2008).
At present, the ClC family contains nine mammalian isoforms, 
ClC-1 to ClC-7 and ClC-K1/ClC-Ka, and ClC-K2/ClC-Kb. Four 
ClC isoforms were shown to function as anion channels and the 
remaining ones to mediate coupled antiport of anions and protons 
(Jentsch, 2008).
ClC-1 is exclusively expressed in adult skeletal muscle and pro-
vides the large resting anion conductance necessary for the electrical 
stability of muscle fibers (Steinmeyer et al., 1991a,b). Mutations in 
the gene encoding ClC-1, CLCN1, cause myotonia congenita (Koch 
et al., 1992; George et al., 1993). ClC-2 is expressed in a broad variety 
of cells. It appears to be important for cell excitability in the central 
nervous system (Kleefuss-Lie et al., 2009; Saint-Martin et al., 2009; 
Foldy et al., 2010; Rinke et al., 2010), as well as for anion resorption 
in various epithelia (Bosl et al., 2001; Catalan et al., 2004; Pena-
Munzenmayer et al., 2005).
ClC-K channels form a subgroup of ClC channels expressed 
mainly in the kidney and the inner ear (Uchida and Sasaki, 2005; 
Sile et al., 2006; Jentsch, 2008). In human, two ClC channels, 
hClC-Ka and hClC-Kb, are expressed in distinct parts of the 
loop of Henle and fulfill transepithelial transport functions that 
are necessary for urinary concentration. Both channels are also 
expressed in the stria vascularis and simultaneous loss of function 
of both channels results in reduced K+ secretion and impaired 
sensory transduction.
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potentials demonstrated a conductive pathway for anions on both 
membrane sides, whereas Na+ appears to diffuse on a paracellular 
pathway (Gross et al., 1975; Imai and Kokko, 1976). In the thick 
ascending limb cooperation of apical Na+–2Cl−–K+ co-transporters 
(NKCC2) and inwardly rectifying potassium channels (ROMK1) 
with basolateral anion channels results in electrogenic transcellular 
NaCl reabsorption (Greger, 1981; Greger and Schlatter, 1981, 1983; 
Greger et al., 1983) (Figure 1A). The thus generated transepithe-
lial voltage provides a driving force for paracellular absorption of 
mono- and divalent cations.
Strial marginal cells and vestibular dark cells of the inner ear 
absorb K+ from the intrastrial fluid space and secrete it into the 
endolymph. K+ secretion is accomplished by basolateral K+ uptake 
by the Na+−2Cl–−K+ co-transporter (NKCC1) and Na+/K+-ATPase 
and apical secretion by a potassium channel consisting of KCNQ1 
pore-forming and KCNE1 accessory subunits (Wangemann et al., 
1995; Shen et al., 1997; Lang et al., 2007). On the basolateral mem-
brane site, Cl– recycles through anion channels (Takeuchi et al., 
1995) (Figure 1B).
physiologiCal roles of ClC-K Channels
Rat ClC-K1 was cloned by Uchida et al. (1993) as the first kidney-
specific ClC isoform. Subsequently, related isoforms from rat (rClC-
K2) and human (hClC-Ka and hClC-Kb) were identified (Adachi 
et al., 1994; Kieferle et al., 1994). Whereas no functional expression 
of the other ClC-K isoforms could be initially achieved (Kieferle 
et al., 1994), rClC-K1 expression in Xenopus oocytes resulted in 
outwardly rectifying anion currents with Br > Cl > I conductivity 
sequence and a permeability sequence of Cl > Br > NO
3
 > I (Uchida 
et al., 1993; Waldegger and Jentsch, 2000). Moreover, anion currents 
glutamate at the amino-terminal end of the F-helix is important. In 
these ion channels, neutralization of this glutamate results in marked 
increases of fast gate open probability suggesting that this side chain 
contributes to the formation of the fast gate (Fahlke et al., 1997; 
Dutzler et al., 2003; Zuniga et al., 2004; de Santiago et al., 2005). 
For ClC-type transporters, neutralization of this “gating glutamate” 
abolishes coupled transport (Accardi and Miller, 2004; Picollo and 
Pusch, 2005; Scheel et al., 2005).
anion Channels in the loop of henle of the Kidney 
and the stria vasCularis of the inner ear
ClC-K channels are expressed predominantly in the loop of Henle 
of the kidney and in the stria vascularis of the inner ear (Figure 1) 
(Uchida, 2000; Estevez et al., 2001). In both types of epithelia anion 
channels with important physiological roles have been known 
for many years (Takeuchi et al., 1995; Wangemann et al., 1995; 
Uchida, 2000; Reeves et al., 2001) and later identified to be ClC-K/
barttin channels.
The loop of Henle is a U-shaped tubule portion that connects 
the proximal and the distal tubule of the nephron (Figure 1). Its 
principal function is to generate a hyperosmotic interstitium using 
counter current mechanisms. An osmotic gradient between tubulus 
lumen and interstitium serves as the driving force for water resorp-
tion in the collecting duct and is thus necessary for urinary con-
centration. Transpithelial transport processes in the thin ascending 
and also in the thick ascending limb of Henle require anion fluxes 
through anion channels (Reeves et al., 2001).
The thin ascending limb of Henle is impermeable to water but 
exhibits an effective passive and electroneutral NaCl transport 
(Figure 1A). Measurements of apical and basolateral membrane 
Figure 1 | Physiological functions of ClC-K channels. (A) Major 
expression sites of ClC-K channels in the nephron. ClC-Ka/ClC-K1 permits 
passive transepithelial transport of chloride in the thin ascending limb of 
Henle. ClC-Kb/ClC-K2 is necessary for secondary-active sodium chloride 
reabsorption in the outer medulla and cortical region of the kidney. (PT, 
proximal tubule; tDL, thin descending limb of Henle’s loop; tAL, thin 
ascending limb of Henle’s loop; TAL, thick ascending limb of Henle’s loop; 
DCT, distal convoluted tubule; CNT, connecting tubule; CCT, cortical collecting 
tubule; CD, collecting duct). (B) Both ClC-Ka/ClC-K1 and ClCKb/ClC-K2 are 
expressed in the marginal cells of the stria vascularis of the inner ear and 
contribute to potassium secretion into the endolymph required for sensory 
transduction in inner hair cells.
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the counter current system necessary for the establishment of the 
corticomedullary osmotic gradient that drives water resorption 
from the collecting duct. In contrast, rClC-K2/hClC-Kb is respon-
sible for anion exit from the basolateral side of the thick ascending 
limb of Henle, supporting secondary-active NaCl resorption in this 
section of the nephron.
Immunohistochemical data demonstrated co-expression of 
both ClC-K channels and barttin in basolateral membranes of mar-
ginal cells in the stria vascularis (Estevez et al., 2001) (Figure 1B). 
Since neither human patients with CLCNKB mutations nor ClC-
K1 knock-out mice exhibit any significant hearing loss, it may be 
deduced therefore that each isoform can act as a substitute for the 
lack of function of the other isoform.
the aCCessory subunit barttin
For many ClC-K isoforms, heterologous expression did not initially 
result in the occurrence of functional anion channels (Kieferle et al., 
1994; Waldegger and Jentsch, 2000). The identification of an acces-
sory ClC-K channel subunit, barttin, provided a molecular basis for 
the lack of functional expression in these cases. Barttin is the gene 
product of BSND, the disease gene of a rare human disease, called 
Bartter syndrome type IV (Birkenhager et al., 2001). Patients with 
Bartter IV suffer from a severe impairment of urinary concentra-
tion ability as well as sensorineural deafness (Landau et al., 1995; 
Jeck et al., 2001). The clinical phenotype suggested that the disease 
gene might encode a subunit of a transport protein expressed in 
the kidney and the inner ear.
In all tested heterologous expression systems, co-expression of 
ClC-K channels with barttin resulted in the occurrence of func-
tional anion channels. Barttin increases the number of ClC-K chan-
nels in the surface membrane of injected oocytes (Estevez et al., 
2001; Waldegger et al., 2002), changes the subcellular distribution 
of ClC-K channels in transfected mammalian cells (Hayama et al., 
2003; Scholl et al., 2006; Janssen et al., 2009), modifies the gat-
ing of rClC-K1 and switches human ClC-K channels from a non-
conducting form into an active form (Scholl et al., 2006; Fischer 
et al., 2010) (Figure 2).
When expressed in MDCK cells without barttin, rClC-K2 was 
reported to reside mainly in the Golgi apparatus (Hayama et al., 2003). 
A different subcellular distribution was described by Scholl et al. 
(2006) who found fluorescent protein-tagged rClC-K1 and hClC-Kb 
to be retained within the endoplasmic reticulum. Co-transfection 
with barttin promotes insertion into the surface membrane often 
resulting in exclusive staining of the surface membrane of transfected 
cells (Scholl et al., 2006). Barttin has profound effects on the glyco-
sylation status of ClC-K channels (Janssen et al., 2009). It stimulates 
complex glycosylation of ClC-K as indicator of effective exit from 
the endoplasmic reticulum. Moreover, since complex glycosylation 
represents a protective mechanism against protein degradation, this 
barttin effect might explain the higher protein stability of ClC-K 
when associated with barttin (Hayama et al., 2003).
In polarized epithelia, heterologously expressed ClC-K/barttin 
channels are located predominantly on the basolateral membrane 
site. Barttin appears to be the major determinant of the polar-
ized insertion of ClC-K/barttin channels in epithelial cells. In the 
absence of ClC-K, barttin inserts preferentially into the basolateral 
membrane of MDCK cells (Janssen et al., 2009). Co-transfection 
in Xenopus oocytes heterologously expressing rClC-K1 channels 
were reduced by pharmacological agents that block transepithelial 
NaCl resorption in the thin ascending limb (Uchida et al., 1995).
rClC-K1 is upregulated in water-restricted animals (Uchida 
et al., 1993), and its deletion in a ClC-K1 knock-out mouse results 
in diabetes insipidus (Matsumura et al., 1999). rClC-K1 knock-out 
mice can maintain salt and water balance under normal condi-
tions but are unable to concentrate urine under water restriction. 
Exogenous application of vasopressin agonists did not increase 
urinary osmolarity even though the integration of water chan-
nels into the collecting duct was intact, indicating that Diabetes 
insipidus resulted from a reduced osmotic gradient in the medulla 
due to impaired function of the thin ascending limb of Henle 
(Matsumura et al., 1999).
In situ hybridization and antibody studies (Vandewalle et al., 
1997; Yoshikawa et al., 1999; Kobayashi et al., 2001) demonstrated 
that rClC-K1 is expressed in the thin ascending limb of Henle. 
RT-PCR experiments additionally detected lower amounts in 
the more distal segments of the nephron (Waldegger et al., 2002; 
Nissant et al., 2004). There are conflicting data about the subcel-
lular distribution of rClC-K1 in the thin ascending limb of Henle. 
Uchida et al. (1995) demonstrated insertion into basolateral as 
well as into apical membranes. However, Vandewalle et al. (1997) 
reported exclusive staining of basolateral membranes in immuno-
histochemical experiments.
The distribution of rClC-K2 in the kidney is relatively wide-
spread. Because of the high degree of sequence similarity between 
rClC-K1 and rClC-K2, no isoform-specific antibody has been gen-
erated so far. However, antibodies binding both rClC-K1 and rClC-
K2 allowed determination of the intrarenal location of rClC-K2 in 
rClC-K1 knock-out mice (Kobayashi et al., 2001). This was found 
in the basolateral membrane of the thick ascending limb of Henle, 
also in the distal tubule and the cortical collecting duct (Uchida, 
2000). With RT-PCR rClC-K2 was found to be highly expressed 
within the outer medulla and cortex but not in the thin ascending 
limb of Henle and other parts of the inner medulla, thus indicat-
ing a different physiological role for rClC-K2 than for rClC-K1 
(Waldegger et al., 2002).
Sequence analysis was not sufficient to relate the human iso-
forms hClC-Ka and hClC-Kb to their mice orthologs, because 
homology between rClC-K1 and rClC-K2 is about 80% compared 
to approximately 80% homology between rClC-K1 and hClC-Ka. 
Kobayashi et al. (2002) generated transgenic mice harboring the 
green fluorescence protein driven by the human ClC-Kb gene pro-
moter to determine the intrarenal distribution of human ClC-Kb. 
They observed fluorescent staining of the thick ascending limb of 
Henle, distal tubules, connecting tubules, and intercalated cells, 
demonstrating close similarity to tissue distributions of rClC-
K2 (Kobayashi et al., 2002). Furthermore, genetic alterations of 
CLCNKB cause Bartter syndrome in human patients (Simon et al., 
1997), a genetic syndrome with symptoms clearly distinct from 
Diabetes insipidus found in ClC-K1 knock-out mice (Matsumura 
et al., 1999). Taken together, these data indicate that hClC-Kb is the 
human homolog of rClC-K2, and hClC-Ka of rClC-K1.
Data reported to date provide compelling evidence that rClC-
K1/hClC-Ka allows passive Cl- transepithelial resorption in the thin 
ascending limb of Henle (Figure 1A). It is a crucial component of 
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the endolymph was observed. However, the endocochlear potential 
was markedly decreased, thus fully explaining the auditory pheno-
type of the mouse model. The authors demonstrated not only lack 
of barttin, but also of ClC-K proteins in the inner ear, indicating 
the importance of barttin for ClC-K protein stability. These find-
ings demonstrate the necessity of ClC-K/barttin channels for the 
endocochlear potential and fully explain sensorineural deafness in 
patients suffering from mutations in BSND.
funCtional properties of rat and human ClC-K 
Channels
So far, three ClC-K isoforms have been functionally studied in 
detail, rat ClC-K1, human ClC-Ka and ClC-Kb (Waldegger and 
Jentsch, 2000; Waldegger et al., 2002; Scholl et al., 2006; Riazuddin 
et al., 2009; Fischer et al., 2010; Zifarelli et al., 2010) (Figure 2). Rat 
ClC-K1 is unique within the known ClC-K isoforms due to its abil-
ity to form functional anion channels without the accessory subunit 
barttin (Figure 2A). The distinct isoforms share a high degree of 
sequence homology (83% among rat isoforms, 91% among human 
isoforms, Kieferle et al., 1994), and at present the basis of the unique 
functional properties of rClC-K1 is not understood.
Rat ClC-K1 channels exhibit pronounced voltage-dependent 
gating that is distinct for channels with or without barttin. In the 
absence of barttin, biphasic voltage-dependent gating indicates 
the coexistence of two processes controlling channel opening and 
closing. Hyperpolarizing voltage steps result in channel activation 
followed by slower deactivation, whereas positive voltage steps elicit 
current deactivation followed by slower activation. Co-expression 
with barttin removes depolarization-induced gating and results in 
monophasic gating with channel opening upon voltage step into 
the negative direction.
rClC-K1 is assumed to share the common architecture of ClC 
channels with two subunits that exhibit two independent ion 
conduction pathways (Miller, 1982; Dutzler et al., 2002). Hence, 
with ClC-K does not modify the subcellular distribution of barttin, 
and optimal co-localization of ClC-K and barttin can be observed. 
A naturally occurring barttin mutation (E88X) abolishes basola-
teral targeting of barttin and results in apical and basolateral inser-
tion of ClC-K/barttin channels (Janssen et al., 2009). At present, 
the regulation of the polarized distribution of ClC-K/barttin in 
epithelia is not fully understood. In contrast to the almost exclusive 
basolateral insertion of ClC-K/barttin in heterologous expression 
systems, anion channels with functional properties resembling 
ClC-K appear to reside also in the apical membrane (Uchida et al., 
1995; Uchida, 2000). One might speculate that ClC-K channels 
could interact with additional subunits.
Although there are hClC-Ka and hClC-Kb channels present in 
the surface membrane, even in the absence of barttin (Estevez et al., 
2001; Scholl et al., 2006), the lack of macroscopic currents indicates 
that these channels are non-functional. This hypothesis was veri-
fied by experiments using heterodimeric concatamers consisting 
of hClC-Kb and hClC-1, a muscle-specific ClC isoform that inserts 
into the plasma membrane independently of barttin (Steinmeyer 
et al., 1991b). Although hClC-Kb reached the surface membrane 
at higher density as a component of such a heterodimeric channel, 
anion currents were undistinguishable from pure hClC-1 currents 
(Scholl et al., 2006). However, co-transfection of the concatamer 
and barttin resulted in anion currents that corresponded to the 
addition of hClC-1 and hClC-Kb/barttin current components. 
Barttin thus controls macroscopic anion currents by determining 
the number of ClC-K channels in the surface membrane as well as 
its ability to conduct anions.
Genetically altered mice that lack barttin in the kidney and in the 
inner ear suffer from severe dehydration and die within a few days 
after birth. Rickheit et al. (2008) therefore engineered inner-ear spe-
cific BSND knock-out mice. These mice suffer from deafness, how-
ever, no impairment of renal function nor any obvious  alteration of 
cochlear morphology could be detected. Moreover, normal [K + ] in 
Figure 2 | representative current recordings of ClC-K channels 
heterologously expressed in mammalian tsA201 cells. Whole-cell patch 
clamp recordings of macroscopic currents of rClC-K1 (A), hClC-Ka (B), and 
hClC-Kb (C) in the absence (upper row) and presence (lower row) of the 
accessory subunit barttin. Channels were studied under nearly symmetrical 
chloride concentrations (pipette solution: 124 mM; bathing solution: 150 mM).
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Currents during the rising phase immediately after the voltage step 
produce lower variances than corresponding anion currents during 
the decaying phase (Figure 3A). This behavior demonstrates the 
existence of two gating processes with different unitary currents 
(Fischer et al., 2010). The slower process exhibits unitary current 
amplitudes that are approximately two-fold larger than for the fast 
process. This finding establishes that individual and cooperative 
gating processes exist in rClC-K1 and that fast gating opens and 
closes individual protopores and slow gating mediates cooperative 
processes. Co-expression of barttin results in the disappearance 
of slow gating of rClC-K1 and in monophasic time dependences 
of rClC-K1/barttin currents (Figure 2A). Currents activate upon 
membrane hyperpolarization, and deactivate at steps to positive 
voltages. Gating of rClC-K1/barttin is comparable to fast gating of 
rClC-K1 in the absence of barttin (Fischer et al., 2010).
ClC-K channels are unique among mammalian ClC channels 
in the absence of the “gating” glutamate that provides fast open-
ing and closing of individual protopores. rClC-K1 nevertheless 
exhibits fast protopore gating. However, a point mutation V166E 
that reconstitutes the lacking glutamate does not install addi-
tional gating processes (Fischer et al., 2010). It causes profound 
alterations of rClC-K1 channel gating that resembles an apparent 
fast and slow gating could either individually affect protopores 
or represent cooperative gating steps that jointly open or close 
both protopores. We used noise analysis (Katz and Miledi, 1970; 
DeFelice, 1981) and single channel recordings to study the molecu-
lar basis of the two different gating processes (Fischer et al., 2010) 
(Figure 3). In double-barreled ion channels, noise may arise from 
common openings and closings of both protopores together, from 
gating of individual protopores or from a combination of both. 
If the individual gates of all protopores are continuously open, 
noise analysis will provide unitary current amplitudes that are twice 
the protopore current amplitude, since unitary gating events will 
correspond to simultaneous openings of both protopores via the 
common gate. Alternatively, if common gates are completely open 
and individual protopores switch between open and closed state, 
currents and variances will indicate the same unitary conductance 
as a single protopore.
Figure 3A shows noise analysis on rClC-K1 current responses to 
a voltage protocol that results in fast activation and consecutive slow 
deactivation in the absence of barttin. A plot of current variances 
versus the corresponding mean current amplitude shows a loop-like 
dependence deviating from the parabolic relationship observed for 
other types of ion channels (Sigworth, 1980; Alvarez et al., 2002). 
Figure 3 | Analysis of the functional stoichiometry of rClC-K1 channels by 
non-stationary noise analysis (A) and single channel recordings (B–D). 
(A) Non-stationary noise analysis of WT rClC-K1 currents in the absence of 
barttin obtained from whole-cell patch clamp recordings of heterologously 
expressed channels in mammalian tsA201 cells. Mean currents (upper traces) 
and variances (middle trace) upon a voltage step that elicits biphasic responses 
result in a loop-like dependence when displayed in a plot of variances versus 
mean current amplitudes (lower panel). (B–D) Inside–out patch clamp 
recordings of mutant V166E rClC-K1 under nearly symmetrical chloride 
concentration (pipette solution: 150 mM; bathing solution: 124 mM). (B) Single 
channel recordings in presence of barttin at +45 and +95 mV show fast 
protopore gating with two equally spaced conductance states. (C) Amplitude 
histogram from bursts of registration at +95 mV. (D) Probabilities of the three 
current levels, closed, open 1 and open 2 at +95 mV (bars). Closed circles 
denote the predicted values for binomially distributed states. (modified from 
Fischer et al., 2010).
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Both rat ClC-K1/barttin and human ClC-Ka/barttin and ClC-Kb/
barttin channels are modified by the composition of the external 
medium. They are blocked upon reduction of external pH (Uchida 
et al., 1995; Estevez et al., 2001; Waldegger et al., 2002). ClC-K 
channels resemble ClC-2 in its external pH dependence (Niemeyer 
et al., 2009) but differ from the muscle-type ClC isoforms, ClC-0 
and ClC-1, that are activated by external protons (Hanke and Miller, 
1983; Fahlke et al., 1996; Rychkov et al., 1996).
rClC-K1/barttin and both human hClC-K/barttin channels are 
unique among ClC isoforms in their sensitivity to external Ca2+ 
(Uchida et al., 1995; Estevez et al., 2001; Waldegger et al., 2002; 
Martinez and Maduke, 2008; Gradogna et al., 2010). Increasing 
external [Ca2+] from 0 to 5 mM increases ClC-Kb/barttin current 
approximately two-fold in Xenopus oocytes (Martinez and Maduke, 
2008). Even more pronounced effects were found for rClC-K1 with-
out barttin (Waldegger et al., 2002) or ClC-Ka/barttin (Martinez 
and Maduke, 2008; Gradogna et al., 2010). The physiological 
importance of the Ca2+-dependence of renal chloride channels is 
unclear. Increased external [Ca2+] will stimulate NaCl absorption 
by the thick ascending limb and thus Ca2+ reabsorption.
Many ClC channels display small unitary current amplitudes. At 
−160 mV, single channel amplitudes of ClC-1 and ClC-2 are about 
280 fA (Pusch et al., 1994; Hebeisen and Fahlke, 2005) and 400 fA 
(Weinreich and Jentsch, 2001; Garcia-Olivares et al., 2008), respec-
tively. Rat ClC-K1 and human ClC-Ka channels displayed voltage-
independent single channel conductances of 33 pS (rClC-K1/barttin) 
and 26 pS (hClC-Ka/barttin) and are thus, to date, the ClC channels 
with the largest unitary conductance. In WT rClC-K1, single chan-
nel current measurements revealed unchanged amplitudes with and 
without barttin. The substitution of valine by glutamic acid (V166E) 
reduces the single channel conductance to 10 pS in the absence and 
22 pS in the presence of barttin (Scholl et al., 2006; Fischer et al., 
2010). Thus, barttin increases unitary current amplitudes of V166E 
rClC-K1, but leaves it unaltered in WT rClC-K1.
For rClC-K2/barttin or hClC-Kb/barttin unitary conductances 
have not yet been investigated in heterologous expression systems. 
However, Lourdel et al. (2003) and Nissant et al. (2004) investigated 
single chloride channels in the basolateral membrane of the murine 
distal convolute tubule and observed channels with low conduct-
ance of ∼9 pS as well as a permeability sequence and pH dependence 
that was comparable to macroscopic currents of rClC-K2/barttin 
and hClC-Kb/barttin in heterologous expression systems.
struCtural determinants of barttin funCtion
The predicted transmembrane topology of barttin consists of two 
transmembrane helices encompassing the amino acids between 
9 and 54 and a large cytoplasmic carboxy-terminus. Using vari-
ous truncation mutants Scholl et al. (2006) demonstrated that key 
functions of barttin are mediated by the transmembrane core and a 
short stretch of amino acids carboxy-terminal to the second trans-
membrane helix. While the transmembrane core of barttin is suf-
ficient for ClC-K channel exit from the endoplasmic reticulum and 
incorporation into the surface membrane, an additional stretch of 
15–17 amino acids (I72X barttin) is necessary to turn hClC-Kb into 
a conductive anion channel (Figure 4). Separate regions of barttin 
thus confer the two functional properties of barttin, activation of 
ClC-K/barttin channels and promotion of membrane insertion.
inversion of the voltage dependence of channel gating (Waldegger 
and Jentsch, 2000; Scholl et al., 2006). Separation of fast and 
slow gating demonstrated that V166E rClC-K1 without barttin 
displays only two distinct gating processes: fast protopore gating 
that is activated by membrane depolarization and slow common 
gating induced by membrane hyperpolarization (Fischer et al., 
2010). An artificial “gating” glutamate in rClC-K1 modifies the 
voltage dependence of fast and slow gating conferred by another 
structural domains.
Single channel recordings of V166E rClC-K1/barttin provided 
definitive proof that fast gating affects exclusively the individual 
protopores (Figure 3B). After a rundown process following patch 
excision we observed long-lasting closures, interrupted by bursts 
of channel openings. In the bursts, rapid transitions between one 
closed and two conductance states occurred. The two conductance 
states were equally spaced and open probabilities were binomially 
distributed (Figures 3C,D). This behavior resembles the binomial 
burst behavior of ClC-0 (Miller, 1982), and demonstrates that there 
is voltage-dependent protopore gating in V166E rClC-K1/barttin 
channels. The open probability of wild type rClC-K1/ barttin 
channels turned out to be too low to permit a similar analysis for 
WT channels.
The functional properties of hClC-Ka and hClC-Kb are different 
from rClC-K1 (Figure 2). hClC-Ka and hClC-Kb channels are not 
active in the absence of barttin (Kieferle et al., 1994; Waldegger and 
Jentsch, 2000; Scholl et al., 2006) but require the accessory subunit 
to become anion conducting (Figures 2B,C). hClC-Ka/ClC-Kb/
barttin channels exhibit time-independent currents upon both 
positive and negative voltage steps (Scholl et al., 2006; Janssen et al., 
2009). In contrast to hClC-Kb/barttin that exhibits bidirectional 
rectification, macroscopic hClC-Ka/barttin conductances decrease 
at very negative potentials, indicating a reduced open probability of 
hClC-Ka/barttin channels. Gating produces high frequency noise 
production at very negative potentials, indicating short closed and 
open states of the channels. Stationary noise analysis allowed deter-
mination of unitary current amplitudes as well as absolute open 
probabilities (Riazuddin et al., 2009). hClC-Ka/barttin channels 
exhibit a linear current–voltage relationship above −100 mV with 
unitary conductance of 26 pS. Absolute open probabilities are 1 at 
voltages positive to 0 mV and decay following a Boltzmann distri-
bution with an inflection point at around −200 mV.
A surprising observation is the clear kinetic difference between 
ClC-K channels expressed in mammalian cells (Scholl et al., 2006; 
Janssen et al., 2009; Riazuddin et al., 2009; Sile et al., 2009) and 
Xenopus oocytes (Estevez et al., 2001; Waldegger et al., 2002; Embark 
et al., 2004; Liantonio et al., 2008; Martinez and Maduke, 2008; 
Zifarelli et al., 2010). When expressed in oocytes, both hClC-Ka/
barttin and hClC-Kb/barttin show time- and voltage-dependent 
gating. Non-stationary noise analysis on excised patches containing 
hClC-Ka/ barttin channels exhibits low open probability at 0 mV 
that increases at negative potentials without indication for satura-
tion (Zifarelli et al., 2010). At present, the reason for this differ-
ence is not clear. One might speculate that unidentified subunits 
in mammalian cells or amphibian oocytes might be the basis of 
this difference. Alternatively, certain intracellular signal cascades 
that modify gating of ClC-K/barttin might exist only in one of the 
two expression systems.
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disease-Causing mutations in ClC-K and barttin
Bartter syndrome is a group of genetic diseases characterized by 
impaired urinary concentration, polyuria, polydipsia, hypokale-
mia, alkalosis, elevated plasma renin and aldosterone, and normal 
blood pressure. Based on differences in the clinical phenotype, 
five different types of Bartter syndrome can be distinguished. For 
each Bartter syndrome, a distinct disease gene has been identi-
fied. In all cases, Bartter genes encode components of the NaCl 
reabsorption machinery in the thick ascending limb of Henle 
(Figure 1). Bartter syndrome type I and type II are caused by 
mutations in the genes encoding NKCC2 and ROMK1, respec-
tively. CLCNKB was identified as underlying disease gene for 
Bartter syndrome type III (Simon et al., 1997). Type V is related 
to gain of function mutations of a calcium-sensing receptor 
that is activated by increased extracellular calcium and inhibits 
NKCC2 and ROMK1 in a G protein-coupled fashion (Hebert, 
2003; Seyberth, 2008).
The majority of disease-causing mutations in CLCNKB induced 
a loss-of-function, resulting either in greatly reduced or absent 
macroscopic anion currents in heterologous expression systems. 
One mutation, R538P (Konrad et al., 2000), caused a change in 
In contrast to initial suggestions the carboxy-terminus is not 
involved in ClC-K/barttin interaction. In co-expression experi-
ments of an isolated carboxy-terminal fragment and hClC-Kb no 
ClC-Kb/barttin currents were observed (Figure 4B). Expression 
of a fluorescent carboxy-terminal fusion protein results in fluo-
rescent staining of the whole cell, since the protein is soluble 
and small enough to diffuse through nuclear pores into the cell 
nucleus (Figure 4H). In co-expression experiments with hClC-Kb, 
no redistribution of the carboxy-terminal fusion protein could be 
observed. Thus, the carboxy-terminus of barttin does not associate 
with ClC-K channel protein.
Tajima et al. (2007) studied interacting domains of barttin and 
ClC-K by co-expression of barttin and rClC-K2 fragments and 
co-immunoprecipitation experiments. They found that barttin 
interacts with the B and the J helix of rClC-K2 and suggested that 
barttin binds to ClC-K in a four-barttin to two-ClC-K subunit 
stoichiometry. Since it appears possible that transmembrane helices 
expose different binding domains in isolation than in the context of 
a full channel, this conclusion awaits further substantiation using 
other experimental approaches. Moreover, direct approaches are 
required to determine the subunit stoichiometry.
Figure 4 | Truncation mutants of barttin affect subcellular distribution and 
functional properties of hClC-Kb channels. (A) Localization of tested carboxy-
terminal truncations that result in functional deficits of barttin. Chaperone function 
of barttin is assigned to the two transmembrane domains. (B) Mean isochronal 
current amplitudes of hClC-Kb determined 2 ms after a voltage step to −155 mV on 
cells co-expressing WT or various truncated versions of barttin. (C–H) Confocal 
images of MDCK cells co-expressing YFP-hClC-Kb (red) and various mutants of 
barttin-CFP (green). Scale bars: 5 μm. (modified from Scholl et al., 2006, Proc. Natl. 
Acad. Sci. U. S. A 103, 11411–11416, copyright (2006) National Academy of 
Sciences, U.S.A).
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importance of subcellular targeting for normal physiology. Increased 
apical anion conductance in the thick ascending limb or in the stria 
vascularis causes significant impairment of epithelial transport proc-
esses and results in deafness and reduced urinary concentration.
Heterologous co-expression of mutant I12T barttin and ClC-K 
channels in mammalian cells demonstrate full activation of the 
channels but reduced insertion into the surface membrane. I12T 
leaves unitary current amplitudes and absolute open probabilities 
of ClC-K/barttin unaffected and only impairs late steps in the intra-
cellular trafficking pathway (Riazuddin et al., 2009).
These data provide an accurate correlation between barttin dys-
function and severity of the clinical phenotype (Figure 5). Only 
mutations that abolish barttin expression, such as Q32X (Janssen 
et al., 2009), or mutations that insert early stop codons (Birkenhager 
et al., 2001) are associated with a severe course and early deteriora-
tion of renal function (Birkenhager et al., 2001; Jeck et al., 2001). In 
contrast, renal function was preserved in all patients carrying barttin 
mutations that do not prevent insertion into the surface membrane. 
Mutations that result only in minor alteration of ClC-K/barttin 
function (G47R) or do not affect the subcellular distribution of bar-
ttin (G10S) were found to have the most benign clinical course.
I12T is the only BSND mutation that almost exclusively impairs 
inner ear function (Riazuddin et al., 2009). The clinical phenotype 
and the alteration of channel function allowed insights into different 
roles of anion conductances in renal and inner ear epithelia. Reduction 
of ClC-K/barttin anion urinary by impaired trafficking results in 
deafness but not in a decreased concentration ability. The inner ear 
seems to be more sensitive than the kidney to a reduction in chloride 
conductances. Moreover, basolateral chloride flux by ClC-K/barttin 
appears to be a rate-limiting step in K+ secretion in the endolymph.
pharmaCology of ClC-K/barttin Channels
ClC-K channels are promising candidates for the treatment of vari-
ous human diseases. Block of ClC-Ka/barttin and ClC-Kb/barttin 
will impair the counter current mechanism in the loop of Henle and 
thus water resorption by the collecting duct. Since basolateral anion 
the calcium sensitivity of hClC-Kb (Martinez and Maduke, 2008). 
However, it is not clear how such a change in calcium sensitivity 
might affect the kidney’s ability to concentrate urine.
There are also naturally occurring CLCNKA and CLCNKB 
mutations that result in a gain-of-function of renal and inner ear 
anion channels. Jeck et al. (2004) studied polymorphic mutations 
in the CLCNKB gene and found that a polymorphism predicting 
T481S is associated with hypertension as well as reduced hearing 
thresholds (Frey et al., 2006). This polymorphism was later found 
to be associated with hypertension in a South Australian popula-
tion (Milton et al., 2006), but not in another study performed by a 
Swedish group (Fava et al., 2007). Hypertension is not only linked 
to CLCNKB, but also to CLCNKA. CLCNKA polymorphisms were 
associated with increased arterial pressure in an Italian population 
(Barlassina et al., 2007). Unfortunately, the functional consequences 
of these polymorphisms have not been reported so far.
Insertion of T481S had pronounced functional effects on 
ClC-Kb in heterologous expression system. In Xenopus oocytes 
(Jeck et al., 2004) and in mammalian cells (Sile et al., 2009) T481S 
ClC-Kb is active even in the absence of barttin. In oocytes, but 
not in mammalian cells, T481S increased ClC-Kb/barttin cur-
rents. These results indicate that T481 plays a crucial role in the 
functional switch between non-conducting and active ClC-Kb by 
barttin (Scholl et al., 2006). Furthermore, it underlines the physi-
ological importance of the functional regulation of ClC-K channels 
by the accessory subunit barttin.
Bartter syndrome type IV is a rare subtype of the Bartter syndromes 
that results in both severe renal salt-wasting and sensorineural deaf-
ness. Fetal polyuria causes maternal polyhydramnios (Landau et al., 
1995; Jeck et al., 2001), and postnatally, salt-wasting and polyuria 
occur as consequences of impaired tubular sodium chloride reab-
sorption. In some patients, renal failure may occur at a young age. 
Since mutations in the BSND gene (Birkenhager et al., 2001) trigger a 
combined dysfunction of ClC-Ka and ClC-Kb (Estevez et al., 2001), 
the identification of digenic mutations in CLCNKA and CLCNKb 
with comparable symptoms to monogenic barttin mutations was 
not surprising (Schlingmann et al., 2004; Nozu et al., 2008).
So far, seven BSND mutations were found in patients with Bartter 
syndrome IV that allow expression of a substantial portion of barttin, 
R8L (Birkenhager et al., 2001), R8W (Birkenhager et al., 2001), G10S 
(Birkenhager et al., 2001; Shalev et al., 2003), G47R (Garcia-Nieto 
et al., 2006), Q32X (Kitanaka et al., 2006), and E88X (Ozlu et al., 2006). 
Additionally, a mutation predicting I12T was identified in four large 
families with non-syndromic deafness (Riazuddin et al., 2009).
R8L, R8W, G10S, and Q32X result in loss-of-function of ClC-K/
barttin channels expressed in mammalian cells (Janssen et al., 2009). 
This finding fully explains deafness and renal salt-wasting in affected 
patients. Q32X abolished surface membrane insertion of ClC-K/
barttin and G47R decreased the number of ClC-K/ barttin channels. 
However, in contrast to Q32X, G47R did not prevent activation of 
hClC-Kb/barttin channels, but rather appears only to reduce the bind-
ing affinity for ClC-K channels. G47R was reported in patients with an 
adult onset of renal symptoms, and the less pronounced renal pheno-
type correlates aptly to the preserved function of G47R barttin.
E88X does not modify the function of ClC-Kb/barttin chan-
nels, but abolishes the preferential insertion of ClC-K/barttin chan-
nels into the basolateral membrane. This finding demonstrates the 
Figure 5 | Disease-causing barttin mutations result in deafness and 
varying severity of renal symptoms depending on the type of functional 
deficits of ClC-K/barttin channels.
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in certain genetic diseases clarified. As in every ion channel, ClC-K/
barttin channels are tightly regulated by intracellular signal cascades 
and many of these regulatory pathways are already known (Estevez 
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2008). Surprisingly, much basic information is still missing. There 
is still uncertainty as to the number of barttin subunits within a 
ClC-K/barttin complex. Although the interaction phase of both 
proteins has been defined (Tajima et al., 2007), it is still unclear how 
barttin exerts the variety of functions on ClC-K proteins (Scholl 
et al., 2006).
Many accessory subunits fulfill functions in conjunction with the 
modification of channel properties (Hidalgo and Neely, 2007). Such 
additional functions have not yet been identified for  barttin. They 
might provide an explanation for the difference in the clinical course of 
Bartter IV patients with missense and non-sense mutations (Figure 5) 
and explain some of the clinical symptoms in this disease that cannot 
be directly explained by dysfunctional epithelial anion channels.
Improved understanding of molecular function as well as 
progress in pharmacotherapy carries the hope for novel therapeutic 
strategies to treat diseases associated with ClC-K/barttin channel 
dysfunction. Some of the clinical conditions are serious and debili-
tating, and such progress is therefore urgently needed.
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currents appear to be a rate-limiting step in K+ secretion by the stria 
vascularis of the inner ear (Riazuddin et al., 2009), stimulation of 
ClC-K/barttin currents will reduce hearing thresholds (Frey et al., 
2006) and potentially improve certain hearing disorders. Moreover, 
ClC-K and barttin dysfunction in Bartter syndrome or in certain 
forms of non-syndromic deafness requires pharmacological res-
toration of ClC-K/barttin channels.
The coexistence of ClC-K/barttin channels in the kidney and the 
inner ear makes isoform-specific medication necessary. The vast 
majority of patients will not tolerate antihypertensive treatment 
causing deafness as side effect. The group of Conte-Camerino has 
focused on the generation of such drugs in recent years (Liantonio 
et al., 2004, 2006, 2008; Picollo et al., 2004). Based on a comparison 
of existing chemical compounds and detailed biophysical analysis 
of the blocking mechanisms (Picollo et al., 2007; Zifarelli et al., 
2010), they produced high affinity blockers for ClC-Ka as well 
as for ClC-Kb by modifying activating compounds (Liantonio 
et al., 2008). It thus appears possible to create novel ligands with 
optimized properties concerning biophysical effects, isoform 
 specificity and affinity to treat the different clinical phenotypes. 
Such rationally designed compounds carry great promises for 
future pharmacotherapy.
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